ReportGemReportGem 中文

PUBLIC COMPANY RESEARCH HUB

ARWR.OQ (ARWR.OQ) Foreign Research Coverage

A focused collection of foreign research coverage for ARWR.OQ, organized by institution and publication date for faster discovery.

Evidence documents3
Filings0
Meetings0
Research3
Displayed research share100%
Latest evidence2026-08-05

Foreign research

Arrowhead Pharmaceuticals Inc: FY3Q26 Earnings: Accelerating SHTG Timelines and Multiple Catalysts Ahead2026-08-05 · Morgan Stanley

M Idea August 5, 2026 12:25 AM GMT Arrowhead Pharmaceuticals Inc | North America Morgan Stanley & Co. LLC Michael E Ulz Equity Analyst FY3Q26 Earnings: Accelerating SHTG Timelines and Multiple Catalysts Ahead Avraham Novick Research Associate Rohit Bhasin …

Arrowhead Pharma Model Update Post CY2Q Print2026-08-05 · JPMorgan

J P M O R G A N North America Equity Research 05 August 2026 Arrowhead Pharma Overweight ARWR, ARWR US Price (04 Aug 26):$89.59 Model Update Post CY2Q Print ▲Price Target (Dec-27):$100.00 Prior (Dec-26):$95.00 …

Arrowhead Pharma An Early STARt Now in Hand with PRV; CY2Q Key Takes2026-08-05 · JPMorgan

J P M O R G A N North America Equity Research 04 August 2026 Arrowhead Pharma An Early STARt Now in Hand with PRV; CY2Q Key Takes Overweight ARWR, ARWR US Price (04 Aug 26):$89.59 SMid Biotechnology …

Questions this evidence can help answer

  • What changed in the latest research coverage of ARWR.OQ?
  • Which operating and valuation themes recur across institutions?
  • Which claims should be checked against company primary-source evidence?
Research this company with AI